Results 161 to 170 of about 325,932 (347)
Screening Using Chronic Kidney Disease Epidemiology Collaboration 2021 Equation Glomerular Filtration Rate Underestimates in Living Kidney Donors Compared With Measurement of Glomerular Filtration Rate. [PDF]
Quintiliano A +9 more
europepmc +1 more source
ABSTRACT Background Predicting the need for permanent pacemaker implantation (PPM) after transcatheter aortic valve implantation (TAVI) is crucial for procedural planning and patient counseling. Aims To evaluate whether left ventricular outflow tract (LVOT) morphology, specifically a tapered configuration, predicts conduction disturbances requiring PPM
Mahmoud Abdelshafy +13 more
wiley +1 more source
Glomerular Filtration Rate by Differing Measures in Predicting Atrial Fibrillation Recurrence After Ablation. [PDF]
Luo F +7 more
europepmc +1 more source
Assessment of Glomerular Filtration Rate in Health and Disease: A State of the Art Review
A. Levey, LA Inker
semanticscholar +1 more source
Association Between D‐amino Acids in Natto (fermented soybeans) and Kidney Dysfunction
XX XX ABSTRACT In this study, we examined clinical and cohort data to explore the potential renoprotective effects of natto (fermented soybeans) consumption and its relationship with D‐amino acids. In a clinical study, ten healthy adults consumed one 40‐g pack of natto three times in a single day, and plasma and urine samples were collected 1 h and 24 ...
Yusuke Nakade +19 more
wiley +1 more source
Accuracy of glomerular filtration rate estimates among patients with cancer. [PDF]
Lees JS +9 more
europepmc +1 more source
Use of plasma clearance of inulin for estimating glomerular filtration rate in cats [PDF]
Scott A. Brown +2 more
openalex +1 more source
Momelotinib, a Janus kinase (JAK) 1/JAK2/activin A receptor type 1 inhibitor, is approved for the treatment of myelofibrosis with anemia. These analyses characterized the population pharmacokinetics of momelotinib and its active metabolite M21 following administration of the commercial tablet formulation in patients with myelofibrosis from phase II/III
Benjamin Rich +5 more
wiley +1 more source

